首页 >
法规速递
-
Document: Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products to address anti-D immunoglobulin supply chain vulnerabilities-2025/7/4
2025-07-07查看详情 > -
Document: Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate <210 mg / 300 mg / 405 mg> powder and solvent for prolonged release suspension for injection)-2024/8/7
2025-08-10查看详情 > -
Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2025/9/24
2025-09-25查看详情 > -
Page: CHMP opinions on consultation procedures-2025/11/3
2025-11-04查看详情 > -
Document: CAT quarterly highlights and approved ATMPs - December 2025-2025/12/2
2025-12-03查看详情 > -
Document: List of signals discussed at PRAC since September 2012-2026/1/6
2026-01-07查看详情 > -
Document: List of eligible industry stakeholder organisations-2026/2/10
2026-02-11查看详情 > -
Document: Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP-2026/3/19
2026-03-20查看详情 > -
Page: Referentials Management Service (RMS)-20256/4/23
2026-04-24查看详情 > -
Document: Timetable: Non-safety referrals-2026/6/4
2026-06-05查看详情 >
